A missense mutation converts the Na+,K+-ATPase into an ion channel and causes therapy-resistant epilepsy

J Biol Chem. 2021 Dec;297(6):101355. doi: 10.1016/j.jbc.2021.101355. Epub 2021 Oct 28.

Abstract

The ion pump Na+,K+-ATPase is a critical determinant of neuronal excitability; however, its role in the etiology of diseases of the central nervous system (CNS) is largely unknown. We describe here the molecular phenotype of a Trp931Arg mutation of the Na+,K+-ATPase catalytic α1 subunit in an infant diagnosed with therapy-resistant lethal epilepsy. In addition to the pathological CNS phenotype, we also detected renal wasting of Mg2+. We found that membrane expression of the mutant α1 protein was low, and ion pumping activity was lost. Arginine insertion into membrane proteins can generate water-filled pores in the plasma membrane, and our molecular dynamic (MD) simulations of the principle states of Na+,K+-ATPase transport demonstrated massive water inflow into mutant α1 and destabilization of the ion-binding sites. MD simulations also indicated that a water pathway was created between the mutant arginine residue and the cytoplasm, and analysis of oocytes expressing mutant α1 detected a nonspecific cation current. Finally, neurons expressing mutant α1 were observed to be depolarized compared with neurons expressing wild-type protein, compatible with a lowered threshold for epileptic seizures. The results imply that Na+,K+-ATPase should be considered a neuronal locus minoris resistentia in diseases associated with epilepsy and with loss of plasma membrane integrity.

Keywords: Na,K-ATPase; arginine mutation; de novo mutation; epilepsy; leak channel.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anticonvulsants / pharmacology
  • Brain / drug effects
  • Brain / metabolism
  • Brain / pathology
  • Cells, Cultured
  • Drug Resistance
  • Epilepsy / drug therapy
  • Epilepsy / genetics*
  • Epilepsy / pathology
  • Humans
  • Infant
  • Molecular Dynamics Simulation
  • Mutation, Missense* / drug effects
  • Protein Subunits / analysis
  • Protein Subunits / genetics
  • Sodium-Potassium-Exchanging ATPase / analysis
  • Sodium-Potassium-Exchanging ATPase / genetics*
  • Xenopus

Substances

  • Anticonvulsants
  • Protein Subunits
  • Sodium-Potassium-Exchanging ATPase